Semaglutide
MARITIME-T2D-3
Novo Nordisk · Phase 3 · Recruiting · Enrollment 1300
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Maridebart cafraglutide | T2D only | n/r | 4 | n/r | n/r |
| Semaglutide | T2D only | n/r | 4 | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Semaglutide
Novo Nordisk · Phase 3 · Recruiting · Enrollment 1300
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Maridebart cafraglutide | T2D only | n/r | 4 | n/r | n/r |
| Semaglutide | T2D only | n/r | 4 | n/r | n/r |